Literature DB >> 28793040

The role of ischemic preconditioning and pentoxifylline in intestinal ischemia/reperfusion injury of rats.

Teresinha Regina Ribeiro de Oliveira1, Geraldo Ferreira de Oliveira2, Ricardo Santos Simões3, Eduardo Hiroshi Tikazawa4, Hugo Pequeno Monteiro5, Djalma José Fagundes6, Murched Omar Taha7.   

Abstract

PURPOSE: : To investigate the role of ischemic preconditioning (IPC) and pentoxifylline (PTX) in intestinal mucosa ischemia/reperfusion injury (IR).
METHODS: : Thirty rats were assigned to 5 groups (N=6): (CG): no clamping of the superior mesenteric artery (90 min.); (IR-SS): saline + ischemia (30 min.) + reperfusion (60 min.); (IR-PTX): PTX + ischemia (30min.) + reperfusion (60 min.); (IPC-IR-SS): 5 min. of ischemia + 5 minutes of reperfusion (IPC) + saline + ischemia (30 min.) + reperfusion (60 min.); (IPC-IR-PTX ): 5 min. of ischemia + 5 min. of reperfusion (IPC) + PTX + 30 min. of I + 60 minutes of R.
RESULTS: : The IR-PTX, IPC-IR-SS and IPC-IR-PTX groups had significantly lower scores of mucosa damage than the IR-SS group. IR-PTX group showed higher scores than the IPC-IR-PTX group, in accordance with the hypothesis of a favorable effect of IPC alone or in association with PTX. Additionally, IPC-IR-SS had a higher damage score than the IPC-IR-PTX. The villi height and crypt depth were similar in all groups. The villi height in the IR-SS was significantly lower.
CONCLUSION: : Ischemic preconditioning or pentoxifylline alone protect the intestinal mucosa from ischemia/reperfusion injury. However, they do not have a synergistic effect when applied together.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28793040     DOI: 10.1590/s0102-865020170070000007

Source DB:  PubMed          Journal:  Acta Cir Bras        ISSN: 0102-8650            Impact factor:   1.388


  1 in total

1.  Atorvastatin Attenuates Radiotherapy-Induced Intestinal Damage through Activation of Autophagy and Antioxidant Effects.

Authors:  Ming-Feng Wei; Ching-Hsueh Cheng; Shu-Yu Wen; Jui-Chueh Lin; Yu-Hsuan Chen; Chun-Wei Wang; Yi-Hsuan Lee; Sung-Hsin Kuo
Journal:  Oxid Med Cell Longev       Date:  2022-08-31       Impact factor: 7.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.